Loco-regional immunotherapy for bladder cancer.
作者信息
Kuss R, Haertig A
出版信息
Prog Clin Biol Res. 1984;162B:321-33.
PMID:6504902
Abstract
摘要
相似文献
1
Loco-regional immunotherapy for bladder cancer.
Prog Clin Biol Res. 1984;162B:321-33.
2
[The immunotherapy and immunoprophylaxis of bladder cancer].
Urol Nefrol (Mosk). 1993 Jul-Aug(4):46-9.
3
4
[Treatment of bladder tumors].[膀胱肿瘤的治疗]
Acta Urol Belg. 1999;67(1):6-10.
5
[BCG therapy. Its role in the treatment of tumors of the bladder].[卡介苗疗法。其在膀胱肿瘤治疗中的作用]
Ann Urol (Paris). 1995;29(5):292-3.
6
[ BCG-immunotherapy and bladder cancer].[卡介苗免疫疗法与膀胱癌]
Prog Urol. 2008 May;18 Suppl 5:S93. doi: 10.1016/S1166-7087(08)72483-7.
7
Immune modifiers in the treatment of bladder cancer.
Prog Clin Biol Res. 1990;350:25-33.
8
Treatment of high-risk, non-muscle-invasive bladder cancer.高危非肌层浸润性膀胱癌的治疗
Nat Clin Pract Urol. 2006 Aug;3(8):398-9. doi: 10.1038/ncpuro0517.
9
Re: Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.回复：高危浅表性膀胱癌的再次经尿道切除术可改善对卡介苗治疗的初始反应。
J Urol. 2006 Jul;176(1):407; author reply 407-8. doi: 10.1016/S0022-5347(06)00593-3.
10
Innovative approaches for superficial bladder tumors.浅表性膀胱肿瘤的创新治疗方法。
Acta Urol Belg. 1996 May;64(2):31-2.
Zotero 插件